DeutschNewstral
Article
The New York Times on 2024-05-06 20:30
First patient, age 12, begins newly approved sickle cell gene therapy
Related news
- Sickle-cell patients dreamed of a cure; enter gene therapyThe New York Times
- A Teenager’s Breakthrough Gene Therapy for Sickle Cell DiseaseThe New York Times
- First Patient Begins Sickle Cell Gene Therapy That F.D.A. ApprovedThe New York Times
Critical advance in gene therapy offers hope to cure sickle cell diseaseStar Tribune
Can gene therapy cure sickle cell anemia?sfbayview.com- TThis gene-editing therapy could cure sickle cell disease, and it’s close to FDA approvalthehill.com
Therapy for sickle cell disease becomes first using gene editing tool to be approved in USthedailyrecord.com
Gene therapy lets a French teen dodge sickle cell diseaseseattletimes.com- DFDA approves CRISPR gene therapy trials for sickle cell diseasedailycal.org
Gene Therapy Lets A French Teen Dodge Sickle Cell Diseasereviewtimes.com
Two gene therapies for sickle cell disease approved in USSeattle Times
Two gene therapies for sickle cell disease approved in U.S.staradvertiser.com
2 gene therapies for sickle cell disease approved in USAlaska Dispatch News- GGene-Editing Recipient of Sickle Cell Treatment Continues to ThriveGuardian Liberty Voice
Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Diseasejdsupra.com- Access barriers loom in Minnesota for blockbuster sickle cell therapyStar Tribune
- Pioneering gene therapy freed her of sickle cell. Is a cure at hand?The New York Times
Revolutionary gene therapy may offer new life for patients battling chronic sickle cell diseasekentucky.com